Literature DB >> 12856716

Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin.

Matthew H Herynk1, Rachael Tsan, Robert Radinsky, Gary E Gallick.   

Abstract

Increased expression and/or activity of c-Met, the receptor protein tyrosine kinase for hepatocyte growth factor/scatter factor, occurs commonly during colon tumor progression. To examine potential roles for c-Met in promoting metastasis, we compared the colon tumor cell line KM12C with low metastatic potential to the isogenic variants KM,12L4 and KM12SM with high metastatic potential. KM12C cells express c-Met with low levels of tyrosine phosphorylation in the absence of HGF. The high metastatic cells express a c-Met that is constitutively tyrosine phosphorylated, they have increased colony formation, and are minimally responsive to HGF relative to the parental cells. Tyrosine-phosphorylated beta-catenin was constitutively associated with c-Met in the more metastatic cells, but was inducible only after HGF addition in the less metastatic cells. Functions mediated by beta-catenin, including cell-cell adhesion and migration, and activation of the tcf (T-cell factor) family of transcription factors, were also elevated in the more metastatic KM12SM and L4 cells. Furthermore, analysis of the known tcf transcriptional target genes, cyclin D1, c-Myc, and uPAR, demonstrated increased expression in the high metastatic cells, correlating with the levels of tcf activity. Collectively, these results suggest that endogenous activation of c-Met in highly metastatic KM12SM CRC cells results in increased survival and growth under anchorage independent conditions, increased in vitro migration, and elevated levels of tcf target genes. Thus, beta-catenin association with activated c-Met may contribute to a more aggressive liver metastatic phenotype of these cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12856716     DOI: 10.1023/a:1024024218529

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  55 in total

1.  Hepatocyte growth factor/scatter factor disrupts epithelial tumour cell-cell adhesion: involvement of beta-catenin.

Authors:  S Hiscox; W G Jiang
Journal:  Anticancer Res       Date:  1999 Jan-Feb       Impact factor: 2.480

Review 2.  The MYC dualism in growth and death.

Authors:  G Fuhrmann; G Rosenberger; M Grusch; N Klein; J Hofmann; G Krupitza
Journal:  Mutat Res       Date:  1999-11       Impact factor: 2.433

3.  Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene.

Authors:  L Schmidt; K Junker; G Weirich; G Glenn; P Choyke; I Lubensky; Z Zhuang; M Jeffers; G Vande Woude; H Neumann; M Walther; W M Linehan; B Zbar
Journal:  Cancer Res       Date:  1998-04-15       Impact factor: 12.701

4.  Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas.

Authors:  M F Di Renzo; M Olivero; T Martone; A Maffe; P Maggiora; A D Stefani; G Valente; S Giordano; G Cortesina; P M Comoglio
Journal:  Oncogene       Date:  2000-03-16       Impact factor: 9.867

5.  Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.

Authors:  V Korinek; N Barker; P J Morin; D van Wichen; R de Weger; K W Kinzler; B Vogelstein; H Clevers
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

Review 6.  Catenins and their associated proteins in colorectal cancer.

Authors:  E L Tucker; M Pignatelli
Journal:  Histol Histopathol       Date:  2000-01       Impact factor: 2.303

Review 7.  Control of beta-catenin signaling in tumor development.

Authors:  J Behrens
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

8.  Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family.

Authors:  M Olivero; G Valente; A Bardelli; P Longati; N Ferrero; C Cracco; C Terrone; S Rocca-Rossetti; P M Comoglio; M F Di Renzo
Journal:  Int J Cancer       Date:  1999-08-27       Impact factor: 7.396

Review 9.  E-cadherin mediated adhesion system in cancer cells.

Authors:  H Shiozaki; H Oka; M Inoue; S Tamura; M Monden
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

10.  Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer.

Authors:  T Takayama; H Shiozaki; Y Doki; H Oka; M Inoue; M Yamamoto; S Tamura; S Shibamoto; F Ito; M Monden
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

View more
  20 in total

1.  Beta-catenin signaling involves HGF-enhanced HepG2 scattering through activating MMP-7 transcription.

Authors:  Fei-Yan Pan; Sheng-Zhou Zhang; Na Xu; Fan-Li Meng; Hong-Xia Zhang; Bin Xue; Xiao Han; Chao-Jun Li
Journal:  Histochem Cell Biol       Date:  2010-07-31       Impact factor: 4.304

Review 2.  Decorin: a guardian from the matrix.

Authors:  Thomas Neill; Liliana Schaefer; Renato V Iozzo
Journal:  Am J Pathol       Date:  2012-06-23       Impact factor: 4.307

Review 3.  Meeting the biologic challenge of colorectal metastases.

Authors:  Harold J Wanebo; Mark LeGolvan; Philip B Paty; Sukamal Saha; Markus Zuber; Michael I D'Angelica; Nancey E Kemeny
Journal:  Clin Exp Metastasis       Date:  2012-10-10       Impact factor: 5.150

4.  Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.

Authors:  Todd W Bauer; Fan Fan; Wenbiao Liu; Marjorie Johnson; Nila U Parikh; Graham C Parry; Jennifer Callahan; Andrew P Mazar; Gary E Gallick; Lee M Ellis
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

5.  Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma.

Authors:  Sang-Uk Han; Hwa-Young Lee; Jae-Ho Lee; Wook-Hwan Kim; Hyunja Nam; Hong Kim; Yong-Kwan Cho; Myung-Wook Kim; Kuhn Uk Lee
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

6.  Family-wide investigation of PDZ domain-mediated protein-protein interactions implicates β-catenin in maintaining the integrity of tight junctions.

Authors:  Taranjit S Gujral; Ethan S Karp; Marina Chan; Bryan H Chang; Gavin MacBeath
Journal:  Chem Biol       Date:  2013-06-20

7.  The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells.

Authors:  Benedetta Peruzzi; Gagani Athauda; Donald P Bottaro
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

8.  Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.

Authors:  Kang Ho Kim; Ho Jun Seol; Eun Hee Kim; Jinguen Rheey; Hyun Jin Jin; Yeri Lee; Kyeung Min Joo; Jeongwu Lee; Do-Hyun Nam
Journal:  Neuro Oncol       Date:  2012-12-20       Impact factor: 12.300

Review 9.  Targeting the Met signaling pathway in renal cancer.

Authors:  Alessio Giubellino; W Marston Linehan; Donald P Bottaro
Journal:  Expert Rev Anticancer Ther       Date:  2009-06       Impact factor: 4.512

10.  Decorin is a novel antagonistic ligand of the Met receptor.

Authors:  Silvia Goldoni; Ashley Humphries; Alexander Nyström; Sampurna Sattar; Rick T Owens; David J McQuillan; Keith Ireton; Renato V Iozzo
Journal:  J Cell Biol       Date:  2009-05-11       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.